Fundraising FoxOCCTE — 2025 Investments
1 investments dated 2025 · listed companies and verified rows first · show all
Genoskingenoskin.cominSep 2025
Genoskin offers MANTIS, a spatial biology platform that performs multiplex 3D imaging analysis of human skin tissue to study immune cell responses to vaccines, drugs, and cosmetics.
BiotechDeep TechMedical Devices
Pascal Descargues, PhD(Founder)in
Co-investorsGrand Sud Ouest CapitalBNP ParibasBpifrance
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.